{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:46:18Z","timestamp":1791639978002,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1017-z","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T08:59:15Z","timestamp":1536051555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Yield of diagnostic tests in unexplained renal hypophosphatemia: a case series"],"prefix":"10.1186","volume":"19","author":[{"given":"A. P.","family":"Bech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J.","family":"Hoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zietse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F. M.","family":"Wetzels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nijenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"issue":"9","key":"1017_CR1","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00467-012-2103-2","volume":"27","author":"J Gattineni","year":"2012","unstructured":"Gattineni J, Baum M. Genetic disorders of phosphate regulation. Pediatr Nephrol. 2012;27(9):1477\u201387.","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"1017_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/qjmed\/hcq039","volume":"103","author":"G Liamis","year":"2010","unstructured":"Liamis G, Milionis HJ, Elisaf M. Medication-induced hypophosphatemia: a review. QJM. 2010;103(7):449\u201359.","journal-title":"QJM"},{"issue":"8","key":"1017_CR3","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","volume":"59","author":"N Weidner","year":"1987","unstructured":"Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer. 1987;59(8):1442\u201354.","journal-title":"Cancer"},{"issue":"9","key":"1017_CR4","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/jbmr.1642","volume":"27","author":"Y Jiang","year":"2012","unstructured":"Jiang Y, Xia WB, Xing XP, et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res. 2012;27(9):1967\u201375.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1017_CR5","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","volume":"13","author":"S Minisola","year":"2017","unstructured":"Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT. Tumour-induced osteomalacia. Nat Rev Dis Primers. 2017;13(3):17044.","journal-title":"Nat Rev Dis Primers"},{"issue":"7929","key":"1017_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","volume":"2","author":"RJ Walton","year":"1975","unstructured":"Walton RJ, Bijvoet OL. Nomogram for derivation of renal threshold phosphate concentration. Lancet. 1975;2(7929):309\u201310.","journal-title":"Lancet"},{"issue":"8","key":"1017_CR7","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1172\/JCI107010","volume":"51","author":"W Jubiz","year":"1972","unstructured":"Jubiz W, Canterbury JM, Reiss E, Tyler FH. Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels. J Clin Invest. 1972;51(8):2040\u20136.","journal-title":"J Clin Invest"},{"issue":"8","key":"1017_CR8","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1093\/ndt\/gfp220","volume":"24","author":"GJ Becker","year":"2009","unstructured":"Becker GJ, Walker RG, Hewitson TD, Pedagogos E. Phosphate levels--time for a rethink? Nephrol Dial Transplant. 2009;24(8):2321\u20134.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1017_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF01623924","volume":"2","author":"S Adami","year":"1992","unstructured":"Adami S, Gatti D, Bertoldo F, et al. The effects of menopause and estrogen replacement therapy on the renal handling of calcium. Osteoporos Int. 1992;2(4):180\u20135.","journal-title":"Osteoporos Int"},{"issue":"2","key":"1017_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0028-2243(92)90058-7","volume":"44","author":"C Castelo-Branco","year":"1992","unstructured":"Castelo-Branco C, Mart\u00ednez de Osaba MJ, Pons F, Gonz\u00e1lez-Merlo J. The effect of hormone replacement therapy on postmenopausal bone loss. Eur J Obstet Gynecol Reprod Biol. 1992;44(2):131\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"1017_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1210\/jcem-61-4-595","volume":"61","author":"JL Stock","year":"1985","unstructured":"Stock JL, Coderre JA, Mallette LE. Effects of a short course of estrogen on mineral metabolism in postmenopausal women. J Clin Endocrinol Metab. 1985;61(4):595\u2013600.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1017_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1210\/jcem.85.3.6456","volume":"85","author":"H Uemura","year":"2000","unstructured":"Uemura H, Irahara M, Yoneda N, et al. Close correlation between estrogen treatment and renal phosphate reabsorption capacity. J Clin Endocrinol Metab. 2000;85(3):1215\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1017_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/0002-9343(84)90987-2","volume":"76","author":"DL Citrin","year":"1984","unstructured":"Citrin DL, Elson P, Kies MS, Lind R. Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implications. Am J Med. 1984;76(5):787\u201393.","journal-title":"Am J Med"},{"issue":"2","key":"1017_CR14","doi-asserted-by":"publisher","first-page":"F249","DOI":"10.1152\/ajprenal.00542.2015","volume":"311","author":"R Webster","year":"2016","unstructured":"Webster R, Sheriff S, Faroqui R, Siddiqui F, Hawse JR, Amlal H. Klotho\/fibroblast growth factor 23- and PTH-independent estrogen receptor-\u03b1-mediated direct downregulation of NaPi-IIa by estrogen in the mouse kidney. Am J Physiol Renal Physiol. 2016;311(2):F249\u201359.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1017_CR15","doi-asserted-by":"publisher","first-page":"F522","DOI":"10.1152\/ajprenal.00386.2014","volume":"308","author":"D Burris","year":"2015","unstructured":"Burris D, Webster R, Sheriff S, et al. Estrogen directly and specifically downregulates NaPi-IIa through the activation of both estrogen receptor isoforms (ER\u03b1 and ER\u03b2) in rat kidney proximal tubule. Am J Physiol Renal Physiol. 2015;308(6):F522\u201334.","journal-title":"Am J Physiol Renal Physiol."},{"issue":"10","key":"1017_CR16","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ki.2008.33","volume":"73","author":"S Faroqui","year":"2008","unstructured":"Faroqui S, Levi M, Soleimani M, Amlal H. Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia. Kidney Int. 2008;73(10):1141\u201350.","journal-title":"Kidney Int"},{"key":"1017_CR17","doi-asserted-by":"crossref","unstructured":"Endo I, Fukumoto S, Ozono K, et al. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone. 2008:1235\u20139.","DOI":"10.1016\/j.bone.2008.02.014"},{"key":"1017_CR18","doi-asserted-by":"crossref","unstructured":"Jonsson KB, Zahradnik R, Larsson T, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med. 2003:1656\u201363.","DOI":"10.1056\/NEJMoa020881"},{"key":"1017_CR19","doi-asserted-by":"crossref","unstructured":"Amblee A, Uy J, Senseng C, Hart P. Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level. Clin Kidney J. 2014:186\u20139.","DOI":"10.1093\/ckj\/sfu004"},{"issue":"1","key":"1017_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/cen.12426","volume":"81","author":"S Jadhav","year":"2014","unstructured":"Jadhav S, Kasaliwal R, Lele V, et al. Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET\/CT vs somatostatin receptor-based functional scans: a series of nine patients. Clin Endocrinol. 2014;81(1):31\u20137.","journal-title":"Clin Endocrinol"},{"issue":"9","key":"1017_CR21","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/1346-8138.12602","volume":"41","author":"R Honda","year":"2014","unstructured":"Honda R, Kawabata Y, Ito S, Kikuchi F. Phosphaturic mesenchymal tumor, mixed connective tissue type, non-phosphaturic variant: report of a case and review of 32 cases from the Japanese published work. J Dermatol. 2014;41(9):845\u20139.","journal-title":"J Dermatol"},{"key":"1017_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bone.2014.04.016","volume":"64","author":"S Breer","year":"2014","unstructured":"Breer S, Brunkhorst T, Beil FT. 68Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT\/CT. Bone. 2014;64:222\u20137.","journal-title":"Bone"},{"issue":"1","key":"1017_CR23","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","volume":"40","author":"K Agrawal","year":"2015","unstructured":"Agrawal K, Bhadada S, Mittal BR, et al. Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med. 2015;40(1):e6\u2013e10.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"1017_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00774-016-0756-9","volume":"35","author":"WJ Yu","year":"2017","unstructured":"Yu WJ, He JW, Fu WZ, Wang C, Zhang ZL. Reports of 17 Chinese patients with tumor-induced osteomalacia. J Bone Miner Metab. 2017;35(3):298\u2013307.","journal-title":"J Bone Miner Metab"},{"issue":"7","key":"1017_CR25","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s00198-017-4007-2","volume":"28","author":"G Gonz\u00e1lez","year":"2017","unstructured":"Gonz\u00e1lez G, Baudrand R, Sep\u00falveda MF, et al. Tumor-induced osteomalacia: experience from a south American academic center. Osteoporos Int. 2017;28(7):2187\u201393.","journal-title":"Osteoporos Int"},{"issue":"1","key":"1017_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1073\/pnas.0902006107","volume":"107","author":"R Goetz","year":"2010","unstructured":"Goetz R, Nakada Y, Hu MC, et al. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-klotho complex formation. Proc Natl Acad Sci U S A. 2010;107(1):407\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1017_CR27","doi-asserted-by":"crossref","unstructured":"Smith ER, Ford ML, Tomlinson LA, et al. Instability of fibroblast growth factor-23: implications for clinical studies. Clin Chim Acta. 2011:1008\u201311.","DOI":"10.1016\/j.cca.2011.02.009"},{"issue":"12","key":"1017_CR28","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1056\/NEJMoa0905647","volume":"362","author":"D Magen","year":"2010","unstructured":"Magen D, Berger L, Coady MJ, Ilivitzki A, Militianu D, Tieder M, Selig S, Lapointe JY, Zelikovic I, Skorecki K. A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome. N Engl J Med. 2010 Mar 25;362(12):1102\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"1017_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/499410","volume":"78","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B, Benet-Pages A, Eckstein G, et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet. 2006 Feb;78(2):193\u2013201.","journal-title":"Am J Hum Genet"},{"issue":"26","key":"1017_CR30","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa010839","volume":"345","author":"J Seufert","year":"2001","unstructured":"Seufert J, Ebert K, M\u00fcller J, et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med. 2001;345(26):1883\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"1017_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1210\/jc.2012-3642","volume":"98","author":"RJ Clifton-Bligh","year":"2013","unstructured":"Clifton-Bligh RJ, Hofman MS, Duncan E, et al. Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET\/CT. J Clin Endocrinol Metab. 2013;98(2):687\u201394.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8 Suppl 1","key":"1017_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0026-0495(96)90077-3","volume":"45","author":"JC Reubi","year":"1996","unstructured":"Reubi JC, Schaer JC, Laissue JA, Waser B. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism. 1996;45(8 Suppl 1):39\u201341.","journal-title":"Metabolism"},{"issue":"7","key":"1017_CR33","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00259-006-0317-x","volume":"34","author":"P Antunes","year":"2007","unstructured":"Antunes P, Ginj M, Zhang H, et al. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging. 2007;34(7):982\u201393.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"1017_CR34","first-page":"502","volume":"47","author":"R Cescato","year":"2006","unstructured":"Cescato R, Schulz S, Waser B, et al. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. J Nucl Med. 2006;47(3):502\u201311.","journal-title":"J Nucl Med"},{"issue":"1","key":"1017_CR35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1359\/jbmr.060909","volume":"22","author":"E Hesse","year":"2007","unstructured":"Hesse E, Moessinger E, Rosenthal H, et al. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography. J Bone Miner Res. 2007;22(1):158\u201362.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1017_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/ki.2010.161","volume":"78","author":"J Meng","year":"2010","unstructured":"Meng J, Ohlsson C, Laughlin GA, et al. Osteoporotic Fractures in Men (MrOs) Study Group. Associations of estradiol and testosterone with serum phosphorus in older men: the osteoporotic fractures in men study. Kidney Int. 2010;78(4):415\u201322.","journal-title":"Kidney Int"},{"key":"1017_CR37","doi-asserted-by":"crossref","unstructured":"Pedersen L, Christensen LL, Pedersen SM, Andersen M. Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial. J Endocrinol Investig. 2017:529\u201338.","DOI":"10.1007\/s40618-016-0597-3"},{"issue":"6","key":"1017_CR38","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1210\/jcem.82.6.3988","volume":"82","author":"R Sih","year":"1997","unstructured":"Sih R, Morley JE, Kaiser FE, Perry HM, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab. 1997;82(6):1661\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1017_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1210\/jcem-69-3-523","volume":"69","author":"JJ St\u0115p\u00e1n","year":"1989","unstructured":"St\u0115p\u00e1n JJ, Lachman M, Zv\u0115rina J, Pacovsk\u00fd V, Baylink DJ. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab. 1989;69(3):523\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1017_CR40","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1210\/jc.2002-021036","volume":"88","author":"BZ Leder","year":"2003","unstructured":"Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab. 2003;88(1):204\u201310.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1017_CR41","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.bone.2006.10.016","volume":"40","author":"SM Burnett-Bowie","year":"2007","unstructured":"Burnett-Bowie SM, Mendoza N, Leder BZ. Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men. Bone. 2007;40(4):913\u20138.","journal-title":"Bone"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1017-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1017-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1017-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:08:13Z","timestamp":1567537693000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1017-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1017"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1017-z","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"22 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Given the retrospective character, no ethical approval was necessary. This is in accordance to our Dutch law on medical scientific research (WMO; Wet medisch-wetenschappelijk onderzoek) and local ethical policies. The law states that no ethical approval is necessary for retrospective research in which patients are not subjected to actions or codes of conduct which are imposed on them. Patients consented in use of their data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The results presented in this paper have not been published previously. None of the authors has a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"220"}}